Cancer, COVID-19, and antiviral immunity: The CAPTURE study
Authors listLewis Au Laura Amanda Boos Anthony Swerdlow Fiona Byrne Scott Shepherd Annika Fendler Samra Turajlic CAPTURE investigators
The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.
Issue number 1